Colorectal Cancer in Young Adults: How a 36-Year-Old’s Early Detection Led to Surgery-Free Recovery
In a medical breakthrough that could reshape treatment protocols for colorectal cancer in younger patients, a 36-year-old woman in South Korea has been successfully treated for early-stage colon cancer using only an endoscopic procedure—avoiding the necessitate for invasive surgery. The case, reported by Korea Biomedical Review and confirmed by the treating hospital, highlights the critical role of early detection and advanced endoscopic techniques in managing a disease that is increasingly affecting adults under 50.
The patient, identified only as “Ms. A,” was referred to Kwangmyeong Hospital at Chung-Ang University after a routine colonoscopy at another facility revealed a large polyp in her sigmoid colon. Despite having no symptoms, the lesion’s size and appearance raised concerns about potential malignancy. A team led by Dr. Min-Jun Kim, a gastroenterologist at the hospital, determined that the polyp was an early-stage colorectal cancer—confined to the mucosal and submucosal layers—and opted for endoscopic submucosal dissection (ESD), a minimally invasive procedure that removes cancerous tissue without cutting into the abdomen.
The success of Ms. A’s treatment underscores a growing trend: colorectal cancer is no longer a disease of the elderly. Global health authorities, including the American Cancer Society, report that incidence rates among adults aged 20–49 have been rising by 1–2% annually since the mid-1990s. In South Korea, colorectal cancer is now the third most common cancer among women in their 30s, a demographic shift that has prompted calls for earlier and more frequent screening.
Why This Case Matters: Rethinking Treatment for Early-Stage Colorectal Cancer
Traditionally, colorectal cancers of Ms. A’s size—typically 2 centimeters or larger—would have been treated with surgical resection, a procedure that removes a portion of the colon and often requires a hospital stay of several days. However, advances in endoscopic techniques like ESD are challenging this paradigm, offering a less invasive alternative for patients with early-stage disease.
ESD, developed in Japan in the late 1990s, allows physicians to remove large, flat, or irregularly shaped polyps in one piece, reducing the risk of recurrence. The procedure involves injecting a solution beneath the lesion to lift it from the underlying tissue, then carefully cutting it away with an electrified knife. Although ESD is technically demanding and requires specialized training, it preserves the colon’s structure and function, sparing patients from the potential complications of surgery, such as infections, adhesions, or long-term digestive issues.
Dr. Kim’s decision to proceed with ESD was based on a meticulous assessment of the polyp’s characteristics. “The lesion was localized, with clear margins and no signs of deep invasion,” he explained in a statement released by the hospital. “This made it an ideal candidate for endoscopic resection.” Pathological analysis of the removed tissue confirmed that the cancer had been completely excised, with no evidence of spread to nearby lymph nodes—a critical factor in determining whether additional treatment, such as chemotherapy, is necessary.
The Rising Tide of Colorectal Cancer in Young Adults
Ms. A’s case arrives amid growing alarm over the increasing prevalence of colorectal cancer in younger populations. In the United States, the Centers for Disease Control and Prevention (CDC) reports that adults born in 1990 have double the risk of colon cancer and quadruple the risk of rectal cancer compared to those born in 1950. Similar trends have been observed in Europe, Australia, and East Asia, prompting the U.S. Preventive Services Task Force to lower the recommended age for routine colonoscopy screening from 50 to 45 in 2021.
The reasons for this surge are not fully understood, but researchers point to a combination of lifestyle and environmental factors. A 2024 study published in The Lancet Gastroenterology & Hepatology identified several key contributors, including:
- Dietary habits: High consumption of processed meats, red meat, and sugary beverages, coupled with low intake of fiber, fruits, and vegetables, has been linked to an increased risk of colorectal cancer.
- Sedentary lifestyles: Prolonged sitting, whether at work or during leisure time, is associated with higher rates of obesity and metabolic disorders, both of which are risk factors for colorectal cancer.
- Alcohol and tobacco use: Heavy alcohol consumption and smoking have been shown to damage the DNA of colon cells, accelerating the development of cancerous growths.
- Gut microbiome changes: Emerging research suggests that alterations in the gut’s bacterial composition, driven by antibiotics, processed foods, and chronic stress, may play a role in colorectal cancer development.
Dr. Elena Martinez, an epidemiologist at the University of California San Diego and co-author of the Lancet study, emphasized that these factors disproportionately affect younger generations. “Millennials and Gen Z are the first cohorts to grow up in an environment where ultra-processed foods are the norm, and physical activity is often limited by screen time,” she said. “These lifestyle shifts are likely contributing to the rise in early-onset colorectal cancer.”
Screening: The First Line of Defense
For Ms. A, the discovery of her cancer was purely incidental—she had no symptoms that would have prompted a doctor’s visit. This is not uncommon; early-stage colorectal cancer often progresses silently, with noticeable symptoms like blood in the stool, unexplained weight loss, or persistent abdominal pain typically appearing only in later stages. By then, the cancer may have spread, making treatment more complex and reducing survival rates.
The case has reignited debates about the optimal age to begin colorectal cancer screening. In South Korea, where the incidence of colorectal cancer is among the highest in the world, the National Cancer Center recommends that adults begin regular screening at age 45. However, some experts argue that high-risk individuals—such as those with a family history of colorectal cancer, inflammatory bowel disease, or certain genetic syndromes—should start even earlier, possibly in their 30s.
Colonoscopy remains the gold standard for colorectal cancer screening, as it allows physicians to both detect and remove polyps during the same procedure. However, other screening methods, such as fecal immunochemical tests (FIT) and stool DNA tests, are also effective and may be more accessible for some patients. The U.S. Preventive Services Task Force recommends that adults aged 45–75 choose a screening method based on their preferences and risk factors, with the frequency of testing varying by the type of test used.
Who Should Consider Early Screening?
While routine screening for average-risk individuals typically begins at age 45, certain groups may benefit from earlier or more frequent testing. These include:
- Individuals with a family history of colorectal cancer: Having a first-degree relative (parent, sibling, or child) diagnosed with colorectal cancer before age 60 increases your risk. In such cases, screening is recommended to begin 10 years before the age at which the relative was diagnosed or at age 40, whichever comes first.
- People with hereditary syndromes: Conditions like Lynch syndrome (hereditary nonpolyposis colorectal cancer) and familial adenomatous polyposis (FAP) significantly increase the risk of colorectal cancer. Genetic testing and early, frequent colonoscopies are often recommended for individuals with these syndromes.
- Patients with inflammatory bowel disease (IBD): Chronic conditions like ulcerative colitis and Crohn’s disease are associated with a higher risk of colorectal cancer. Patients with IBD may need to begin screening 8–10 years after their diagnosis and continue with regular surveillance.
- Individuals with lifestyle-related risk factors: Obesity, heavy alcohol use, smoking, and a diet low in fiber and high in processed foods are all modifiable risk factors. While these do not necessarily warrant earlier screening, they underscore the importance of adopting healthier habits and discussing risk with a healthcare provider.
The Future of Colorectal Cancer Treatment: Less Invasive, More Precise
Ms. A’s successful treatment with ESD reflects broader trends in oncology toward minimally invasive, organ-preserving therapies. For colorectal cancer, these advancements include:
- Endoscopic mucosal resection (EMR): A technique similar to ESD but typically used for smaller polyps. EMR involves snaring the polyp with a wire loop and cutting it away, often in multiple pieces.
- Transanal endoscopic microsurgery (TEM): A procedure used for early-stage rectal cancers, TEM allows surgeons to remove tumors through the anus without making external incisions.
- Robotic surgery: Increasingly used for more advanced cancers, robotic-assisted surgery offers greater precision and flexibility than traditional laparoscopic surgery, potentially reducing recovery times.
- Immunotherapy and targeted therapies: For patients with advanced or metastatic colorectal cancer, new drugs that target specific genetic mutations or harness the immune system are improving survival rates and quality of life.
Despite these advances, experts caution that not all patients with early-stage colorectal cancer are candidates for endoscopic treatment. Factors such as the size, location, and depth of invasion of the tumor, as well as the patient’s overall health, must be carefully considered. “ESD is a powerful tool, but it’s not a one-size-fits-all solution,” said Dr. Kim. “The key is early detection, which gives us more options for treatment and better outcomes for patients.”
What Which means for Young Adults: A Call to Action
Ms. A’s story is a stark reminder that colorectal cancer does not discriminate by age. While the disease remains more common in older adults, the rising incidence in younger populations demands greater awareness and proactive health measures. Here’s what young adults can do to reduce their risk and catch the disease early:
- Know the symptoms: While early-stage colorectal cancer often has no symptoms, warning signs can include changes in bowel habits (such as diarrhea or constipation), blood in the stool, unexplained weight loss, fatigue, and persistent abdominal discomfort. If you experience any of these symptoms, consult a healthcare provider promptly.
- Understand your risk: If you have a family history of colorectal cancer or other risk factors, talk to your doctor about when to start screening. Genetic counseling may be recommended for individuals with a strong family history of the disease.
- Adopt a healthier lifestyle: Reduce your intake of processed meats, red meat, and sugary foods, and increase your consumption of fiber-rich fruits, vegetables, and whole grains. Regular physical activity and maintaining a healthy weight can also lower your risk.
- Limit alcohol and avoid smoking: Both alcohol and tobacco use are linked to an increased risk of colorectal cancer. If you drink, do so in moderation, and if you smoke, seek support to quit.
- Advocate for your health: If you’re under 45 and have concerns about colorectal cancer, don’t hesitate to discuss screening options with your doctor. While guidelines may not recommend routine screening for average-risk individuals in this age group, exceptions can be made based on individual circumstances.
Key Takeaways
- Early detection saves lives: Ms. A’s case demonstrates that early-stage colorectal cancer can often be treated with minimally invasive procedures like ESD, avoiding the need for surgery and preserving quality of life.
- Colorectal cancer is rising in young adults: Incidence rates among adults under 50 have been increasing globally, driven by lifestyle and environmental factors. Screening guidelines have been adjusted to reflect this trend, with many health authorities now recommending routine screening beginning at age 45.
- Lifestyle changes can reduce risk: A diet rich in fiber, regular physical activity, limited alcohol consumption, and avoiding smoking can all help lower the risk of colorectal cancer.
- Know your family history: Individuals with a family history of colorectal cancer or certain genetic syndromes may need to begin screening earlier and undergo more frequent testing.
- Symptoms should not be ignored: While early-stage colorectal cancer often has no symptoms, persistent changes in bowel habits, blood in the stool, or unexplained weight loss should prompt a visit to the doctor.
What’s Next?
Ms. A will continue to undergo regular follow-up colonoscopies to monitor for recurrence, a standard practice for colorectal cancer survivors. Meanwhile, her case has sparked renewed interest in the potential of endoscopic treatments for early-stage colorectal cancer, particularly in younger patients. Researchers at Chung-Ang University and other institutions are exploring ways to refine ESD techniques and expand their use, with the goal of making surgery-free treatment an option for more patients.
For the broader medical community, the challenge lies in raising awareness about the rising incidence of colorectal cancer in young adults and ensuring that patients and providers alike recognize the importance of early detection. As Dr. Kim noted, “The earlier we catch colorectal cancer, the more options we have for treatment—and the better the outcomes. This case is a testament to the power of vigilance and innovation in medicine.”
Have you or someone you know been affected by colorectal cancer? Share your story in the comments below, and help raise awareness about the importance of early detection and screening.